Vilagletistat - HY-19359
Nur noch %1 verfügbar
Catalog #
HY-19359
Ab
362,00 €
ZED-1227 is a specific and orally active transglutaminase 2 (TG2) inhibitor, with an IC50 of 45 nM. ZED-1227 can block inflammation-induced TG2 expression and activity. ZED-1227 can be used for the research of celiac disease (CeD)[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-19359/Vilagletistat-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | ZED-1227 |
| CAS | 1542132-88-6 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 528.60 |
| Solubility | DMSO : 125 mg/mL (ultrasonic) |
| Clinical Information | Phase 2 |
| Target | Glutaminase |
| Application: | COVID-19-immunoregulation |
|---|